4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-24-026666
EVP and Chief Legal Officer sold 3,756 shares at $53.76 ($201,923)
- EVP and Chief Legal Officer acquired 18,757 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Parschauer Karah Herdman · EVP and Chief Legal Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-01 | Grant or award : show line 1 in the form | +17,800 | 69,782 | D | ||
| 2024-03-01 | Grant or award : show line 2 in the form | +957 | 70,739 | D | ||
| 2024-03-01 | Sale : show line 3 in the form | −3,756 | $53.76 | $201,923 | 67,340 | D |
| Open-market sales · 3,756 sh · avg $53.76 · $201,923 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-01 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +31,400 | 31,400 | D |
Loading xslF345X05/ownership.xml…